Thus phosphorylation and inhibition of TCTP by insulin may serve as potential targets for therapeutic interventions to mitigate TCTP-related diseases and conditions that might include vascular hyperreactivity, sodium pump dysregulation, hypertension, and diabetes mellitus. This evidence concerns the gene TPT1 and Hypertension.